News

Our Research News

• Major Journal Reports on S.L.E. Lupus Foundation Fellow’s Finding that Skin Lupus in Infancy Predicts Cardiac Lupus in Next Child
• Activity Helps Prevent Cardiovascular Disease in Lupus
• Congratulations to California Scientist Greg Barton, PhD!
• Lupus Research Institute Announces a “Breakthrough Decade”: $100 Million for Innovative Lupus Research
• Lupus LA’s Research Partner Announces 2009 Novel Research Grants
• More Good News for Lupus at the American College of Rheumatology Meeting
• Lupus Research Institute Investigator Leads Discovery on Key Blood Anticoagulant
• Lupus Research Institute Encouraged by Phase 2 Trial Results of Experimental Drug Epratuzumab
• Funding for Lupus Discoveries Tops $70 Million
• Success of LA Researchers Spurs Millions in Additional $$ to Expand Lupus Work
• Fueling Discovery in California and Beyond
• Rituxan Results, Although Disappointing, Can Help Create Better Drugs and Build Better Trials for Lupus
• Lupus Research Institute Launches Novel Studies in Human Lupus
• Apply for a Research Grant
• Clinical Trials for Lupus Underway After Decades of Drought
• Listen to Lupus Experts on Trials Before Treatments
• Profound Immune System Discovery Opens Door to Halting Destruction of Lupus
• Lupus Research Institute Discoveries Blaze New Paths to Understanding and Treating Lupus
  
• Lupus Research Institute Advocacy Victory
  

Research News Archive »

Lupus in the News

• CVD Risk in Lupus Worse for Men and Older Patients
• Nurse Fights Lupus With Help From Friend
• Sisters Helping Sisters: Study in Sisters of Women with SLE
• The Lupus Drug Gold Mine
• Twin Epigenetics Study IDs Methylation Differences in Lupus
• ImmuPharma PLC: Encouraging Final Phase IIb Results Seen with LUPUZOR(TM) in Systemic Lupus Erythematosus
• Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of Benlysta™ in Systemic Lupus Erythematosus
• ACR: Depression and CVD Linked in Patients with Lupus
• Genetic Link to Lupus
• The Body Count at Home
• UPDATE 2-UCB, Immunomedics drug shows promise for lupus
• OMRF researchers link vitamin D deficiency with lupus
• Immune responses to flu vaccine are diminished in lupus patients
• Lupus drug passes key test, researchers say
• Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for Benlysta™
• Human Genome's Lupus Drug Shows Success in Trials; Shares Jump
• Lupus-Relevant Recovery Act Awards
• Study: Bone-building drug blocks effects of steroids
• Birth Control Pills Linked to Lupus Risk
• NIH Recovery Act Program Opportunity for Faculty Development — $100 Million Reserved
• Letter from Dr. Stephen I. Katz: More Funding Opportunities related to the American Recovery and Reinvestment Act (ARRA)
• Gene linked to lupus might explain gender difference in disease risk
• Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
• Rituximab Reduces Kidney Inflammation in Patients with Lupus
• Clinical trial is halted for lupus drug Riquent

Lupus News Archive »

Lupus Drug Development

Read about the latest lupus drug research and clinical trial results More »